awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35841620-48BAE2BC-3193-43B7-92E6-055C0B691AFF
Q35841620-48BAE2BC-3193-43B7-92E6-055C0B691AFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35841620-48BAE2BC-3193-43B7-92E6-055C0B691AFF
Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study
P2860
Q35841620-48BAE2BC-3193-43B7-92E6-055C0B691AFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35841620-48BAE2BC-3193-43B7-92E6-055C0B691AFF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed5e0edf45923ba05dff82c90380c152c215759b
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.